Author

Wen-Hao Pang

Institutions: Peking University, State Key Laboratory of Natural and Biomimetic Drugs

Observed institutions: Peking University, State Key Laboratory of Natural and Biomimetic Drugs

OpenAlex ID: A5075853305

Synergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core–shell nanoparticles

2014 · Qiang Feng, Min-Zhi Yu, et al. · Biomaterials · 150

Core-Shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery

2013 · Ling-Yan Gao, Xiao-Yan Liu, et al. · Biomaterials · 113

Microfluidic-Based Holonomic Constraints of siRNA in the Kernel of Lipid/Polymer Hybrid Nanoassemblies for Improving Stable and Safe In Vivo Delivery

2020 · Wei Wei, Jing Sun, et al. · ACS Applied Materials & Interfaces · 50

Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer

2016 · Min-Zhi Yu, Wen-Hao Pang, et al. · European Journal of Pharmaceutical Sciences · 38

The role of disulfide-bridge on the activities of H-shape gemini-like cationic lipid based siRNA delivery

2016 · Xiao-Fei Ma, Jing Sun, et al. · Journal of Controlled Release · 28

Polyarginine-Mediated siRNA Delivery: A Mechanistic Study of Intracellular Trafficking of PCL-R15/siRNA Nanoplexes

2020 · Hai-Tao Zhang, Minzhi Yu, et al. · Molecular Pharmaceutics · 15

Works count: 6

Citation count: 394

H-index: 6

I10-index: 6